Dr. Reddy’s Laboratories launches Doxercalciferol Injection

22 Nov 2019 Evaluate

Dr. Reddy’s Laboratories has launched Doxercalciferol Injection,4 mcg/2 ml (2 mcg/ml) multiple-dose vials, the therapeutic generic equivalent of Hectorol (doxercalciferol) injection 4 mcg/2 ml (2 mcg/ml) Multiple - Dose Vials, approved by the U.S. Food and Drug Administration (USFDA).

The Hectorol injection 4 mcg/2 ml (2 mcg/ml) single-dose vials and multiple-dose vials brand and generics had U.S. sales of approximately $138 million MAT for the most recent twelve months ending in September 2019 according to IQVIA Health.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharm aceuticals in India and overseas.

Dr. Reddys Lab Share Price

1175.55 -10.90 (-0.92%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×